VICAL INC Business Finance Contracts & Agreements
40 Contracts & Agreements
- Funding Agreements (1 contract)
- Investment Agreements (1)
- Purchase Agreements (8)
- Registration Rights Agreements (2)
- Security Agreements (2)
- Stock Agreements (8)
- Underwriting Agreements (7)
- Warrant Agreements (11)
- Amendment No. 1 to Asset Purchase Agreement, dated as of July 21, 2023, by and among Fresh Tracks Therapeutics, Inc., Brickell Subsidiary, Inc., Botanix SB Inc., and Botanix... (Filed With SEC on July 21, 2023)
- Fresh Tracks Therapeutics, Inc. Employee Stock Purchase Plan (Filed With SEC on March 30, 2023)
- Acknowledgment and Agreement Related to Asset Purchase Agreement and Amended and Restated License Agreement, dated as of November 10, 2022, by and among Fresh Tracks Therapeutics,... (Filed With SEC on November 14, 2022)
- Fresh Tracks Therapeutics, Inc. Employee Stock Purchase Plan (Filed With SEC on November 14, 2022)
- Subscription and Investment Representation Agreement, dated May 25, 2022, by and between Brickell Biotech, Inc. and the purchaser signatory thereto (Filed With SEC on May 25, 2022)
- Asset Purchase Agreement, dated as of May 3, 2022, by and among Brickell Biotech, Inc., Brickell Subsidiary, Inc., Botanix SB Inc., and Botanix Pharmaceuticals Limited (Filed With SEC on May 3, 2022)
- Amended and Restated Underwriting Agreement, dated July 19, 2021, by and between Brickell Biotech, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on July 22, 2021)
- BRICKELL BIOTECH, INC. EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on April 19, 2021)
- Form of Underwriting Agreement (Filed With SEC on October 22, 2020)
- Form of Underwriting Agreement (Filed With SEC on October 19, 2020)
- Form of Warrant Agency Agreement (Filed With SEC on October 13, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on October 13, 2020)
- Form of Warrant to Purchase Common Stock (Filed With SEC on October 13, 2020)
- Form of Warrant Agency Agreement (Filed With SEC on June 17, 2020)
- Form of Warrant to Purchase Common Stock (Filed With SEC on June 17, 2020)
- Form of Underwriting Agreement (Filed With SEC on June 17, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on June 8, 2020)
- Form of Warrant to Purchase Common Stock (Filed With SEC on June 8, 2020)
- Form of Underwriting Agreement (Filed With SEC on June 8, 2020)
- Registration Rights Agreement, dated February 17, 2020, by and between Brickell Biotech, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on February 18, 2020)
- Purchase Agreement, dated February 17, 2020, by and between Brickell Biotech, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on February 18, 2020)
- Series B Warrant issued by Brickell Biotech, Inc. to Lincoln Park Capital Fund, LLC (Filed With SEC on February 18, 2020)
- Series A Warrant issued by Brickell Biotech, Inc. to Lincoln Park Capital Fund, LLC (Filed With SEC on February 18, 2020)
- Securities Purchase Agreement, dated February 17, 2020, by and between Brickell Biotech, Inc. and Lincoln Park Capital Fund, LLC (schedules omitted) (Filed With SEC on February 18, 2020)
- Orca Pharmaceuticals LLC Asset Purchase Agreement, dated June 6, 2013, by and between Brickell Biotech, Inc. and Orca Pharmaceutics (Filed With SEC on September 3, 2019)
- U.S. Security Agreement, dated August 31, 2019, by and between Brickell Biotech, Inc. and NovaQuest Co-Investment Fund X, L.P (Filed With SEC on September 3, 2019)
- Registration Rights Agreement, dated August 31, 2019, by and between Brickell Biotech, Inc. and NovaQuest Co-Investment Fund X, L.P (Filed With SEC on September 3, 2019)
- Panmira Pharmaceuticals LLC Purchase Agreement, dated January 30, 2015, by and between Brickell Biotech, Inc. and Panmira Pharmaceuticals (Filed With SEC on September 3, 2019)
- Funding Agreement, as amended, dated June 2, 2019, by and between Brickell Biotech, Inc. and NovaQuest Co-Investment Fund X, L.P (Filed With SEC on September 3, 2019)
- Form of Warrant Certificate (Filed With SEC on September 3, 2019)
- STOCK PURCHASE AGREEMENT (Filed With SEC on August 9, 2016)
- VICAL INCORPORATED Common Stock ($0.01 par value per share) AT-THE-MARKET EQUITY OFFERING SALES AGREEMENT (Filed With SEC on November 7, 2012)
- 13,333,334 Shares VICAL INCORPORATED Common Stock ($0.01 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on January 9, 2012)
- 15,000,000 Shares VICAL INCORPORATED Common Stock ($0.01 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on September 24, 2010)
- COMMON STOCK PURCHASEAGREEMENT Dated as of January 8, 2010 by and between VICAL INCORPORATED and AZIMUTH OPPORTUNITY LTD. TABLE OF CONTENTS (Filed With SEC on January 8, 2010)
- COMMON STOCK PURCHASE WARRANT VICAL INCORPORATED (Filed With SEC on May 22, 2009)
- VICAL INCORPORATED DELAYED ISSUANCESTOCK PURCHASE ELECTION AGREEMENT (Filed With SEC on March 3, 2009)
- MASTER SECURITY AGREEMENT No. 6081123 (Filed With SEC on August 25, 2006)
- STOCK PURCHASE AGREEMENT (Filed With SEC on August 7, 2006)
- VICAL INCORPORATED DELAYED ISSUANCE STOCK PURCHASE GRANT NOTICE (Filed With SEC on March 15, 2005)